Cited by 198CRISPR and Genetic EngineeringRNA regulation and diseaseDNA and Nucleic Acid Chemistry

Structural basis for Cas9 off-target activity

Open access
Pacesa, Martin, Lin, Chun-Han, Cléry, Antoine, Saha, Aakash, Arantes, Pablo R., Bargsten, Katja, Irby, Matthew J., Allain, Frédéric H.-T. +4 more·2022·Cell

Published version of a preprint

Abstract

The target DNA specificity of the CRISPR-associated genome editor nuclease Cas9 is determined by complementarity to a 20-nucleotide segment in its guide RNA. However, Cas9 can bind and cleave partially complementary off-target sequences, which raises safety concerns for its use in clinical applications. Here, we report crystallographic structures of Cas9 bound to bona fide off-target substrates, revealing that off-target binding is enabled by a range of noncanonical base-pairing interactions within the guide:off-target heteroduplex. Off-target substrates containing single-nucleotide deletions relative to the guide RNA are accommodated by base skipping or multiple noncanonical base pairs rather than RNA bulge formation. Finally, PAM-distal mismatches result in duplex unpairing and induce a conformational change in the Cas9 REC lobe that perturbs its conformational activation. Together, these insights provide a structural rationale for the off-target activity of Cas9 and contribute to the improved rational design of guide RNAs and off-target prediction algorithms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2022.09.026

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Off-target effects remain a major challenge for CRISPR/Cas systems in translational medicine.

    “Although CRISPR/Cas systems exhibit tremendous potential in translational medicine, off-target effects remain a major challenge (Fu et al., 2013; Hsu et al., 2013; Pacesa et al., 2022).”

    From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Pacesa et al., 2022

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 97 · Cited by 198

Research works printed but not linked: 1

  1. Pacesa M, and Jinek M. (2021). Mechanism of R-loop formation and conformational activation of Cas9. bioRxiv, 2021.2009.2016.460614.

Authors
Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., Donohoue, P. D., & Jinek, M.
Affiliations
  • Caribou Biosciences (United States) (US)
  • ETH Zurich (CH)
  • University of California, Riverside (US)
  • University of Zurich (CH)
Venue
Cell
Publisher
Elsevier BV
Published
2022-10
Volume
185
Issue
22
Pages
4067-4081.e21
ISSN
0092-8674 (ISSN-L)
OpenAlex
W4307725211
Cited by
198
References
97
Citations by year
2026: 39 · 2025: 69 · 2024: 49 · 2023: 35 · 2022: 6
FWCI
13.06
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation (R01GM141329, 1905374)
  • Howard Hughes Medical Institute
  • Vallee Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182567)
  • Paul Scherrer Institut
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01GM141329)
  • Division of Chemistry (CHE-1905374)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
Keywords
Cas9, off-target effects, CRISPR/Cas9, guide RNA, heteroduplex, nuclease specificity, off-target prediction, guide RNA design, crystal structure
MeSH terms
Gene Editing, RNA, Guide, CRISPR-Cas Systems, Endonucleases, Nucleotides, RNA, Guide, Kinetoplastida, Base Pairing, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review